Researchers have been excited about the medication , a novel dual treatment showing promising outcomes in early trials for size reduction . It acts by modulating several hormones : GLP-1 and GIP, which , when engaged , support regulate hunger and improve metabolism . Initial observations suggest substantial weight reduction and potential benefits f